31 results
8-K
EX-99.1
SAVA
Cassava Sciences Inc
3 Aug 22
Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
9:25am
to evaluate an innovative method to detect FLNA without the use of antibodies. For business, technical and personnel reasons, we continue to prioritize
8-K
EX-99.1
nvem7sros egdl
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-99.1
cvrh06s7
25 Mar 19
Pain Therapeutics Reports 2018 Financial Results and Corporate Update
12:00am
8-K
EX-99.1
v7fw9vmyrmy 04505ec9
8 Feb 19
Pain Therapeutics Announces Feedback from
4:04pm
8-K
EX-99.1
tjrmzrxsjet
6 Aug 18
Other Events
7:00am